English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduMedications commonly known as puberty blockers were found to delay development of female reproductive organs but allow for restoration of reproductive functioning after the medications were withdrawn, according to a new study being presented this week at the American Physiology Summit.
Tag: transgender medicine
Gender Affirmation Treatment Delivery Route May Affect Heart Health
Transgender and gender diverse (TGD) people assigned male at birth are at increased heart health risk. The delivery route of estrogen medication is known to affect heart health risk in cisgender women. However, research is lacking on how estrogen route affects heart health in the TGD population.
Rural, transgender populations face greater healthcare disparities, WVU research show
New research from West Virginia University suggests that transgender and gender diverse individuals in rural areas face greater challenges receiving basic healthcare needs than their counterparts. Up to 61% of participants said they had to travel out of state for gender-related care, while over one-third reported they avoid seeking healthcare altogether for fear of discrimination.
Longest study of its kind reveals how gender-affirming hormone therapies impact obesity among U.S. transgender individuals
Researchers conducted the largest and longest observational study to date, using multiple body weight measurements among a racially and ethnically diverse population of gender diverse individuals treated at an academic medical center and non-profit community health center in Washington, D.C. The findings suggest that transgender patients taking gender-affirming hormone therapy should be monitored for changes in body weight, body mass index and for complications that may accompany high body weight, such as cardiovascular disease.
Transgender teenagers deserve same access to medical care as other youth
The Endocrine Society and a coalition of LGBTQ+ youth and reproductive health organizations argued in a joint submission to the High Court of England and Wales that transgender teenagers should be able to give informed consent to treatment the same way teenagers with other medical conditions can.
Endocrine Society applauds AMA resolution supporting access to gender-affirming care
The Endocrine Society—a professional organization of more than 18,000 health care providers and scientists worldwide—praised the American Medical Association’s House of Delegates for passing a resolution opposing efforts to criminalize medical care for transgender youth.
Endocrine Society and partners to intervene in U.K. transgender medicine court appeal
The United Kingdom’s High Court has granted permission for a coalition of LGBTQ+, youth, reproductive health and medical organizations, including the Endocrine Society, to intervene in an appeal of its decision that minors under age 16 likely could not give informed consent for pubertal suppression.